Investing Profile

Kiersten Stead

VCInvestor
Managing Partner at DCVC Bio
dcvc.com/bio/core/dr-kiersten...San Francisco, California
Photo of Kiersten Stead, Managing Partner at DCVC Bio
Your Intro Paths to Kiersten Stead

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Kiersten is a member of
University of Alberta Network
22 CONNECTIONS
University of Alberta Network
22 CONNECTIONS
University of Alberta Network
22 CONNECTIONS
University of Alberta Network
22 CONNECTIONS
University of Calgary Network
21 CONNECTIONS

Find Kiersten Stead on

cb
Current Investing Position
DCVC Bio Managing Partner
Investment Range
$5.0M - $25.0M
Sweet Spot
$15.0M
Investments On Record
19

Kiersten Stead is on these Sector & Stage Rankings

Kiersten Stead's Investments On Record (16)

CompanyStageDateRound SizeTotal Raised
Latus Bio
Series AMay 2026$43M
Series AMay 2024$54M
$97M
Co-investors: Francisco Gimenez (8VC)
Grove Biopharma
Series AApr 2025$30M
$30M
Elo Life Systems
Series AJan 2024$21M
$21M
Totus Medicines
Series BDec 2023$66M
$110M
Co-investors: Jason Pontin (DCVC (Data Collective)), John Hamer (Financial Services, Financial Technology, and Business Services), Sarah Cone (Prequel Strategies)
Novome Biotechnologies
Series BSep 2022$44M
Series AJan 2020$33M
$82M
Co-investors: Andrew Schwab (5am Ventures), Dan Janney (IDF)
Creyon Bio
Series AMar 2022$40M
$40M
Co-investors: Zavain Dar (Dimension Capital)
Plexium
Series BFeb 2022$100M
Series AOct 2019$28M
$170M
Co-investors: Tim Kutzkey (The Column Group), Rob Hopfner (Pivotal Life Sciences), Adam Goulburn (6 Dimensions Capital), Josh Wolfe (Lux Research)
BreezeBio
SeedDec 2018$9M
$18M
Co-investors: Roelof Botha (Sequoia Capital), Nisa Leung (Qiming Venture Partners)

Kiersten Stead's Experience

Board Member Nilo Therapeutics2024 - Present
Board Member Radionetics Oncology2024 - Present
Board Member Totus Medicines2024 - Present
Board Member Latus Bio2024 - Present
Board Member Mycoworks2019 - Present
Managing Partner DCVC Bio2018 - Present
SAB Keystone Symposia on Molecular & Cellular Biology2014 - Present
Board Observer UnderstoryPresent
Board Member Numerion LabsPresent
Board Member BreezeBioPresent
Board Member X-37Present
Board Member MycoWorksPresent
Board Member Verdant RoboticsPresent
Board Member Novome BiotechnologiesPresent
Board Member AHFMR ForeFront MBAPresent
Board Member Grove BiopharmaPresent
Board Member and Co-Founder PairwisePresent
Board Member Stemson Therapeutics2021 - 2024
Board Member Elo Life Systems2022 - 2024
Board Member Creyon Bio2021 - 2024
Board Member Sabanto2018 - 2024
Board Member Verdant Robotics, Inc.2019 - 2022
Board Member Plexium2018 - 2022
Board Member GenEdit2018 - 2021
Core Evaluation Team, Genomic Applications Partnership Program Genome Canada2013 - 2020
Board Member and Co-Founder Pairwise Plants2017 - 2018
Board Member Combyne Ag2017 - 2018
Board Observer Understory, Inc.2016 - 2018
Board Member PlantResponse Biotech2015 - 2018
Investment Director Monsanto Growth Ventures2013 - 2018
Board Observer Blue River Technology2015 - 2017
Member Board Of Directors VitalFields2015 - 2016
Venture Capital Burrill & Company2011 - 2013
Business Development Associate TEC Edmonton2010 - 2011
Scholar AHFMR ForeFront MBA2009 - 2011
Research Associate University of Alberta2009 - 2010
Post-Doc University of Alberta2007 - 2009

Kiersten Stead's Education

University of Alberta B.Sc. Cellular, Molecular and Microbial Biology
University of Calgary B.Sc. Cellular, Molecular and Microbial Biology
University of Alberta Ph.D. Molecular Biology and Genetics
University of Alberta Ph.D. University of Alberta Ultimate Team
University of Alberta MBA Finance Specialization

Investors who invest with Kiersten Stead

Sign in with Google →

Scouts & Angels Affiliated With Kiersten Stead

Sign in with Google →